Embecta Corp. (NASDAQ: EMBC) was unchanged Tuesday, as the global diabetes care company with a 100-year legacy in insulin delivery announced a new landmark publication in the Mayo Clinic Proceedings.

Tidepool Loop was cleared only for use by people with Type 1 diabetes who are aged 6 and older. Embecta, meanwhile, will tap into Tidepool’s software expertise to develop an automated algorithm ...

Logo for BD’s Diabetes Care business spinoff: embecta – BD “The Diabetes Care business can trace its roots back nearly 100 years to BD’s introduction of the world’s first specialized ...

Additionally, highlights from the ceremony will be shared across embecta's social media channels. Please visit embecta for additional information regarding Diabetes Awareness Month.

In Singapore alone, the number of residents with diabetes is expected to reach 1 million by 2050. “embecta is committed to supporting Singapore’s fight in the war against diabetes.